Veterinary Medicines Information website

DV8WORM 50 mg/144 mg/200 mg Tablets for dogs

Authorised
  • Praziquantel
  • Pyrantel embonate
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
DV8WORM 50 mg/144 mg/200 mg Tablets for dogs
Active substance:
  • Praziquantel
  • Pyrantel embonate
  • Fenbendazole
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
  • Fenbendazole
    200.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Immediate packaging material: polyethylene containerPackage size: • polyethylene container containing 200 tablets
  • Immediate packaging material: PVC/Alu blister Package size: • carton box containing PVC/Alu blister of 1x10 tablets
  • Immediate packaging material: PVC/Alu blister Package size: • carton box containing PVC/Alu blister of 2x10 tablets
  • Immediate packaging material: PVC/Alu blister Package size: • carton box containing PVC/Alu blister of 10x10 tablets
  • Immediate packaging material: PVC/Alu blister Package size: • carton box containing PVC/Alu blister of 20x10 tablets
  • Immediate packaging material: PVC/Alu blister Package size: • carton box containing PVC/Alu blister of 1x2 tablets
  • Immediate packaging material: PVC/Alu blister Package size: • carton box containing PVC/Alu blister of 3x2 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Duggan Veterinary Supplies Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pernix Pharma Kft.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10400/001/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 29/09/2024
Updated on: 14/03/2026
Download